A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
about
Therapeutic Strategies for Oxidative Stress-Related Cardiovascular Diseases: Removal of Excess Reactive Oxygen Species in Adult Stem CellsHistological Characteristics, Fatty Acid Composition of Lipid Fractions, and Cholesterol Content of Semimembranosus and Triceps Brachii Muscles in Maremmana and Limousine Bovine BreedsDetection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics.Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats.A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvThe AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model.Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context.Hyperlipidemic Inhibitory Effects of Phellinus pini in Rats Fed with a High Fat and Cholesterol Diet.Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK) lowering cardiovascular disease riskRegulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol
P2860
Q28077974-494BE7EB-E553-4B16-8DE7-F41EB4D0E335Q33794527-CC215F6E-3CD7-4888-899F-429B7D6B1C9DQ39414910-1A1A2C59-49F7-43DA-BCF2-888AD8547003Q40970388-ECD14D79-168C-40FB-A484-A4B3CCE7C5F2Q41573128-082AD8D5-1225-4F6C-83CF-FADE10AE5D40Q47242605-3C27FF7F-1CEC-4858-A29F-1219D6FA6838Q48113239-9E228726-1A27-40EA-AA88-537962624C18Q50931633-7A128BC8-B768-410E-B405-B73BA92252B7Q51113879-E4E7E012-B6D3-4563-8C40-D87814C74CE6Q51329562-2086825C-8CD7-40F8-909B-A45869FC73D2Q55362816-C739D7DD-D910-4E04-AD58-9754B78D0B89Q55510348-1BD9E5BC-B727-4EFF-85B2-D7375AA239B2Q57817370-AAB45124-3898-4789-9E63-4CE31D0464CCQ58701054-73F46BED-B094-4AC8-94FA-EB29CBBC1F1C
P2860
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A review of low-density lipopr ...... isease morbidity and mortality
@ast
A review of low-density lipopr ...... isease morbidity and mortality
@en
A review of low-density lipopr ...... isease morbidity and mortality
@nl
type
label
A review of low-density lipopr ...... isease morbidity and mortality
@ast
A review of low-density lipopr ...... isease morbidity and mortality
@en
A review of low-density lipopr ...... isease morbidity and mortality
@nl
prefLabel
A review of low-density lipopr ...... isease morbidity and mortality
@ast
A review of low-density lipopr ...... isease morbidity and mortality
@en
A review of low-density lipopr ...... isease morbidity and mortality
@nl
P2093
P921
P3181
P1476
A review of low-density lipopr ...... isease morbidity and mortality
@en
P2093
Dylan L Steen
Irfan Khan
JoAnne M Foody
P304
P3181
P356
10.1016/J.JACL.2015.11.010
P407
P577
2016-01-01T00:00:00Z